Lord Jim O’Neill of Gatley
Chairman, Antimicrobial Resistance Review
Director, Pandemics and Emerging Threats, Office of Global Affairs, Health and Human Services
Vice President for Programs and Director of Global Health Policy, Center for Global Development
Antimicrobial resistance (AMR) threatens future growth and prosperity, as well as health. Without global action, the UK's Review on Antimicrobial Resistance, led by Lord Jim O'Neill, estimates that an additional 10 million people will die every year from drug-resistant infections and the global economy will experience a loss of $100 trillion by 2050. The impact from rising drug resistance will be felt worldwide, hitting low- and middle-income countries hardest.